Company intelligence / Profile preview

Neuronity Therapeutics

Mansfield, Massachusetts, United Statesneuronitytx.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Neuronity Therapeutics is an active biotech startup founded in Massachusetts in 2022 that develops first-in-class immunotherapies targeting age-related neurodegenerative diseases such as Parkinson’s disease, Lewy body dementia, and multiple system atrophy. Their innovative approach focuses on boosting the brain's natural immunity by engineering or pharmacologically transforming central nervous system-resident or blood-derived immune cells to clear toxic alpha-synuclein protein aggregates responsible for synucleinopathies.

Therapeutic areas
Neurology
Modalities
Immune cell engineeringGene and cell therapyPharmacological agents transforming CNS immune cellsAdoptive Cell Therapy
Industry
Biotech
02

Drug pipeline

2 assets

NiT-1

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Neuronity Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronity Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call